ATL to Host Webcast on Top Reasons to Consider LIMS as SaaS
News Jun 14, 2014
Accelerated Technology Laboratories, Inc. (ATL) will host the fifth in their 2014 series of webcasts on Wednesday, June 18, 2014, to share information on leveraging LIMS as a Software as a Service (SaaS) model. A hosted LIMS is a great choice for small to medium size organizations that do not have the capital needed for their own servers or the software purchase, or lack an internal IT department to manage a local solution. A hosted solution can allow these organizations to deploy and implement a robust LIMS often more quickly and with less upfront cost as compared to the traditional purchased model. A cloud based LIMS can give organizations that traditionally could not afford a LIMS, the ability to have a high functioning LIMS to optimize their resources and grow their business.
With SaaS solutions, all clients need is a web browser and internet access. Whereas traditional solutions can take weeks or even months to deploy, SaaS solutions do not require software installation, so clients are able to access new software almost immediately following configuration for their organization.
SaaS solutions allow clients to log in from anywhere with Internet and a compatible browser, facilitating access for those telecommuting, or individuals that work across multiple sites.
Primary advantages of SaaS LIMS will be discussed in detail within this webcast. Recommended attendees include laboratory and quality managers in the analytical, food & beverage, manufacturing (product/material testing), agriculture, energy, environmental, water/wastewater, life science, pharmaceutical, biotechnology, and public health
Neural Computer Hears Like HumansNews
Modelling the human senses is an incredibly complex task. Our brains arrange cells into complex hierarchies that process information from our surroundings. Now, a group at MIT have created a model of the human auditory cortex that can hear sounds and music in the same way that humans do.READ MORE
Stable Beta-Amyloid Dimers Identified in Alzheimer’s BrainsNews
A recent study exploited state-of-the-art mass spectrometry to provide the first direct evidence of beta-amyloid dimers in patients with Alzheimer’s disease and points to the potential of these molecules as biomarkers. Beta-amyloid dimers may be the smallest pathological species that trigger Alzheimer’s disease.
Deceased Data: Should Your Online Remains Be Treated Like Physical Remains?News
In 2018, your death doesn't just leave behind a body. It leaves behind a huge online footprint - your digital remains. A new study asks whether these remains should be treated and respected as a corpse would, and whether museums may provide a blueprint for the preservation process.READ MORE